Thalassemia - NYSORA

Explore NYSORA knowledge base for free:

Thalassemia

Learning objectives

  • Difference between α- and β thalassemia
  • Recognize thalassemia
  • Management of thalassemia

Definition and mechanisms

  • Thalassemia is an inherited group of hematological disorders
  • Synthesis of alpha or beta globin chains is deficient, characterized by decreased hemoglobin production
  • More frequently found in the Mediterranean, Central Africa, China, and South East Asian regions
  • The majority of hemoglobin is HbA in normal adults, which has two α and two β chains, i.e. α2β2

α thalassemia

  • α0 thalassemia results from the elimination of α1 and α2 genes and/or regulatory sequences
  • α+ thalassemia minor results from a single gene deletion or point mutation that prevents normal α chain production
    • The resulting anemia is mild and of little anesthetic significance
  • Hemoglobin H disease is caused by the interaction of α0 and α+ determinants (loss of three genes)
    • The clinical picture is of chronic hemolytic anemia with Hb levels of 8–10 g dL
    • Stimulates erythropoietin production and results in excess production of large amounts of β-chains
  • α thalassemia major” occurs when all four alpha globin genes are non-functioning
    • Is almost uniformly fatal in utero without intervention

β thalassemia

  • Is an autosomal recessive defect of the beta-globin chains of the hemoglobin A molecule
  • The clinical presentation typically manifests at approximately 4 to 6 months of age
  • A defect in one beta globin allele will result in beta thalassemia minor
    • An effective carrier state as individuals are usually asymptomatic or present with anemia
    • Hemoglobin levels 2-3 g/dL < normal for age
  • A defect in both alleles results in beta thalassemia major (Cooley anemia) 
    • Results in profound anemia requiring lifelong blood transfusions

Signs and symptoms

Intravascular hemolysis:Perioperative anemia
Jaundice, gallstones
Splenic sequestration causes anemia and other hematological effects
Free iron causes a vascular endothelial inflammatory response and its consequences, e.g. leading to systemic and Pulmonary hypertension (PH), cerebral ischemia, platelet activation, hypercoagulability
Extramedullary erythropoiesis:Frontoparietal bossing, prominent maxilla and zygomatic arch, compression of neural structures in bony canal including the spinal cord, bony deformities e.g. thoracic cage, spinal column
Systemic effects of anemia:High output cardiac failure, decreased oxygen delivery leading to poor growth
Multiple transfusions:
Hypervolemia, coagulation defects, immunosuppression, iron overload
Iron overload:Cardiomyopathy, cardiac hypertrophy, myocarditis, pericarditis
Liver failure and cirrhosis
Renal tubular dysfunction, loss of concentrating renal function, and increased excretion of
calcium, magnesium, and phosphate
Endocrionpathy (diabetes, hypothyroidism, hypoparathyroidism, adrenal insufficiency)
Immunosuppression: increased risk of infection

Diagnosis

  • Complete blood count
  • Hemoglobin electrophoresis
  • DNA-testing
  • Metzer index, not a definitive test but in can suggest the possibility of thalassemia

Management

Thalassemia, hematocrit, hemoglobin, thrombocytopenia, splenomegaly, splenectomy

Suggested reading

  • Pollard BJ, Kitchen, G. Handbook of Clinical Anaesthesia. Fourth Edition. CRC Press. 2018. 978-1-4987-6289-2.
  • Thomas, C., Lumb, A.B., 2012. Physiology of haemoglobin. Continuing Education in Anaesthesia Critical Care & Pain 12, 251–256.
  • Wilson, M., Forsyth, P., Whiteside, J., 2010. Haemoglobinopathy and sickle cell disease. Continuing Education in Anaesthesia Critical Care & Pain 10, 24–28.

We would love to hear from you. If you should detect any errors, email us customerservice@nysora.com